HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Short interfering RNA directed against the SLUG gene increases cell death induction in human melanoma cell lines exposed to cisplatin and fotemustine.

AbstractBACKGROUND:
Melanoma remains largely resistant to currently available chemotherapy, and new strategies have been proposed to flank standardized therapeutic protocols in an effort to improve efficacy. Such an approach requires good knowledge of the mechanisms involved in the resistance and survival of melanoma cells. In this context, the SLUG gene has recently been characterized as a major regulator of melanocytes and melanoma cell survival.
METHODS:
We tested the hypothesis that an oligonucleotide-based short interfering RNA (siRNA) directed against the SLUG gene increases the susceptibility of melanoma cells to drugs such as cisplatin and fotemustine, which are frequently used to treat this cancer.
RESULTS:
It was found that SLUG siRNA increased cisplatin-induced cell death and rendered the drug active in vitro at half its plasmatic peak concentration. Such activity was correlated with an upregulation of the pro-apoptotic gene, PUMA. Furthermore, SLUG siRNA increased the capacity of fotemustine to elicit cell death and induced p21WAF1 upregulation, resulting in cell cycle arrest. Interestingly, this pathway did not require functional p53.
CONCLUSION:
These findings suggest that SLUG siRNA enhances the efficacy of two of the most widely used drugs to treat melanoma.
AuthorsIvan Vannini, Massimiliano Bonafe, Anna Tesei, Marco Rosetti, Francesco Fabbri, Gianluca Storci, Paola Ulivi, Giovanni Brigliadori, Dino Amadori, Wainer Zoli
JournalCellular oncology : the official journal of the International Society for Cellular Oncology (Cell Oncol) Vol. 29 Issue 4 Pg. 279-87 ( 2007) ISSN: 1570-5870 [Print] Netherlands
PMID17641412 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Nitrosourea Compounds
  • Organophosphorus Compounds
  • RNA, Small Interfering
  • SNAI1 protein, human
  • Snail Family Transcription Factors
  • Transcription Factors
  • Tumor Suppressor Protein p53
  • fotemustine
  • Cisplatin
Topics
  • Antineoplastic Agents (pharmacology)
  • Cell Cycle (drug effects)
  • Cell Death (drug effects)
  • Cell Line, Tumor
  • Cisplatin (pharmacology)
  • DNA Mutational Analysis
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Humans
  • Melanoma (genetics, pathology)
  • Nitrosourea Compounds (pharmacology)
  • Organophosphorus Compounds (pharmacology)
  • RNA, Small Interfering (genetics, metabolism)
  • Snail Family Transcription Factors
  • Transcription Factors (antagonists & inhibitors, genetics, metabolism)
  • Tumor Suppressor Protein p53 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: